ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $290,000 | +37.4% | 1,683 | 0.0% | 0.00% | – |
| Q2 2021 | $211,000 | -7.5% | 1,683 | 0.0% | 0.00% | – |
| Q1 2021 | $228,000 | -17.1% | 1,683 | -21.8% | 0.00% | – |
| Q4 2020 | $275,000 | +95.0% | 2,151 | +71.9% | 0.00% | – |
| Q3 2020 | $141,000 | -17.1% | 1,251 | -29.9% | 0.00% | – |
| Q2 2020 | $170,000 | +102.4% | 1,785 | +91.7% | 0.00% | – |
| Q1 2020 | $84,000 | -16.8% | 931 | -51.0% | 0.00% | – |
| Q4 2019 | $101,000 | +1583.3% | 1,900 | +1800.0% | 0.00% | – |
| Q3 2018 | $6,000 | -84.6% | 100 | -87.5% | 0.00% | – |
| Q2 2018 | $39,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |